These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Percutaneous versus surgical delivery of autologous myoblasts after chronic myocardial infarction: an in vivo cardiovascular magnetic resonance study. Larose E, Proulx G, Voisine P, Rodés-Cabau J, De Larochellière R, Rossignol G, Bertrand OF, Tremblay JP. Catheter Cardiovasc Interv; 2010 Jan 01; 75(1):120-7. PubMed ID: 19859959 [Abstract] [Full Text] [Related]
27. Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. Meluzín J, Janousek S, Mayer J, Groch L, Hornácek I, Hlinomaz O, Kala P, Panovský R, Prásek J, Kamínek M, Stanícek J, Klabusay M, Korístek Z, Navrátil M, Dusek L, Vinklárková J. Int J Cardiol; 2008 Aug 18; 128(2):185-92. PubMed ID: 17764767 [Abstract] [Full Text] [Related]
28. Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cells. Lutz M, Rosenberg M, Kiessling F, Eckstein V, Heger T, Krebs J, Ho AD, Katus HA, Frey N. Cardiovasc Res; 2008 Jan 18; 77(1):143-50. PubMed ID: 18006465 [Abstract] [Full Text] [Related]
29. Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells. Zenovich AG, Davis BH, Taylor DA. Handb Exp Pharmacol; 2007 Jan 18; (180):117-65. PubMed ID: 17554507 [Abstract] [Full Text] [Related]
30. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Dill T, Schächinger V, Rolf A, Möllmann S, Thiele H, Tillmanns H, Assmus B, Dimmeler S, Zeiher AM, Hamm C. Am Heart J; 2009 Mar 18; 157(3):541-7. PubMed ID: 19249426 [Abstract] [Full Text] [Related]
35. Cell therapy for heart failure--muscle, bone marrow, blood, and cardiac-derived stem cells. Ott HC, Davis BH, Taylor DA. Semin Thorac Cardiovasc Surg; 2005 Mar 18; 17(4):348-60. PubMed ID: 16428043 [Abstract] [Full Text] [Related]
36. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Zeng L, Hu Q, Wang X, Mansoor A, Lee J, Feygin J, Zhang G, Suntharalingam P, Boozer S, Mhashilkar A, Panetta CJ, Swingen C, Deans R, From AH, Bache RJ, Verfaillie CM, Zhang J. Circulation; 2007 Apr 10; 115(14):1866-75. PubMed ID: 17389266 [Abstract] [Full Text] [Related]
40. Cell transplantation after the coculture of skeletal myoblasts and mesenchymal stem cells in the regeneration of the myocardium scar: an experimental study in rats. Carvalho KA, Guarita-Souza LC, Hansen P, Rebelatto CL, Senegaglia AC, Miyague N, Olandoski M, Francisco JC, Furuta M, Gremski W. Transplant Proc; 2006 Jun 10; 38(5):1596-602. PubMed ID: 16797364 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]